Duloxetine (Cymbalta): a new SNRI for depression.
D000284:Administration, Oral; D019388:Cytochrome P-450 CYP1A2 / Q000378:metabolism; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism; D003863:Depression / Q000188:drug therapy*; D004347:Drug Interactions / Q000502:physiology; D000068736:Duloxetine Hydrochloride; D006207:Half-Life; D006801:Humans; D008099:Liver / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013876:Thiophenes / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D019388:Cytochrome P-450 CYP1A2; D019389:Cytochrome P-450 CYP2D6; D000068736:Duloxetine Hydrochloride; D017367:Selective Serotonin Reuptake Inhibitors; D013876:Thiophenes